Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA?

Infect Dis (Lond). 2019 Jan;51(1):77-78. doi: 10.1080/23744235.2018.1518585. Epub 2018 Oct 14.

Authors

Massimiliano Lanzafame¹, Sebastiano Rizzardo², Daniela Piacentini², Emanuela Lattuada², Sheila Chiesi³, Sandro Vento⁴

Affiliations

¹ a Diagnosis and Therapy of HIV Infection Unit , G.B. Rossi University Hospital , Verona , Italy.
² b Infectious Diseases Unit , G.B. Rossi University Hospital , Verona , Italy.
³ c Department of Medicine , School of Medicine, Nazarbayev University , Astana , Kazakhstan ;
⁴ d University Medical Center , Astana , Kazakhstan.

PMID: 30317907
DOI: 10.1080/23744235.2018.1518585

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Adult
Female
HIV Infections / drug therapy*
HIV Infections / virology*
HIV Integrase Inhibitors / administration & dosage*
Heterocyclic Compounds, 3-Ring / administration & dosage*
Humans
Male
Medication Adherence*
Oxazines
Piperazines
Pyridones
RNA, Viral / blood*
Retrospective Studies
Treatment Outcome
Viral Load*

Substances

HIV Integrase Inhibitors
Heterocyclic Compounds, 3-Ring
Oxazines
Piperazines
Pyridones
RNA, Viral
dolutegravir